RxDoctor Payments Data

Andrew Gruenzel, MD

Pain Medicine · Willoughby, OHNPI 1548793177

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,731 of the $10,210 with a category attached, or 65.9%. 25 manufacturers reported payments, led by MML US, Inc. at 27.0% of the total.

$10,210in general payments, 2019–2025

Across 184 payments — averaging $55.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • MML US, Inc.$3K
  • Boston Scientific$3K
  • Medtronic$2K
  • Relievant Medsystems, Inc.$1K
  • Abbott$708
  • SPR Therapeutics, Inc$280
  • plus $1K from 19 others

What the payments were for

  • Travel & lodging$3,48034%
  • Food & beverage$6,73166%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,210 in reported general payments places this provider in the 80th percentile of 245 pain medicine providers in Ohio.

See all pain medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$72,847
Medicare patients
197
Services billed
853

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl43$24,419
MovantikNaloxegol Oxalate15$6,220
Buprenorphine19$5,774
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen215$5,030
Pregabalin180$4,878
Gabapentin286$4,365
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen227$4,029
Duloxetine Hcl128$2,224
Celecoxib68$1,464
Tramadol Hcl190$1,437
Oxycodone Hcl61$1,159
Tizanidine Hcl122$1,145
Lidocaine11$1,139
Methocarbamol59$809
Morphine Sulfate ErMorphine Sulfate32$795

Paid to pharmacies, not to this prescriber.

Other pain medicine in Willoughby

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →